Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +0.59% | +2.41% | +20.57% |
May. 02 | ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000 | MT |
Financials (USD)
Sales 2024 * | 325K | Sales 2025 * | 7.46M | Capitalization | 115M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 356 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15.5 x |
P/E ratio 2024 * |
-1.85
x | P/E ratio 2025 * |
-2.17
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.42% |
Latest transcript on aTyr Pharma, Inc.
1 day | +0.59% | ||
1 week | +2.41% | ||
Current month | +8.28% | ||
1 month | -2.30% | ||
3 months | -10.99% | ||
6 months | +52.47% | ||
Current year | +20.57% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.7 | +0.59% | 4,636,559 |
24-05-10 | 1.69 | -1.74% | 224,343 |
24-05-09 | 1.72 | +1.78% | 214,054 |
24-05-08 | 1.69 | -0.59% | 271,164 |
24-05-07 | 1.7 | +2.41% | 256,475 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.57% | 115M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- LIFE Stock